- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Eli Lilly and Company (NYSE:LLY): Current price $52.88
Lilly and its wholly owned subsidiary Avid Radiopharmaceuticals, said late Tuesday that Amyvid (Florbetapir F 18 Injection) has received European Commission marketing authorization as a diagnostic radiopharmaceutical that is indicated for Positron Emission Tomography imaging of beta-amyloid neuritic plaque density in the brains of adult patients suffering from cognitive impairment who are being studied for Alzheimer’s disease and other causes of cognitive impairment. In is noted that Amyvid should be used in conjunction with a clinical evaluation.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.